The results showed that the relevant BPs on mogroside V action against the COVID-19/ovarian cancer target mainly involved binding of DNA-binding transcription factor, growth factor receptor, cytokine receptor, RNA polymerase II-specific DNA-binding transcription factor and siRNA, and activities of DNA-binding transcription activator, protein kinase C, calcium-dependent protein kinase C, and histone kinase. The gene discussed is MYCNOS; the disease is COVID-19.